Co-Diagnostics Files to Sell Up to $25M in Stock

Dec

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.

Jan

Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Menu

Co-Diagnostics Files to Sell Up to $25M in Stock

To read the full story....

Breaking News

In Brief This Week: Inspirata, PerkinElmer, Foundation Medicine, and More

FDA Allows Marketing of Roche MRSA Test

Takeda, Enzyre Collaborate on At-Home Coagulation Test for Hemophilia

Philips, Paige Partner to Market Clinical-Grade AI Technology for Pathologists

Centogene Q3 Revenues Decrease 13 Percent Due to Non-Recurring Payments From Pharma Partners

VolitionRx, Gyros Protein Technologies Win Eurostar Grants for Lung Cancer Dx

Featured White Papers

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

What's Popular?

NCCN Updates Genetic Testing Guidelines for Assessing Breast, Ovarian, Pancreatic Cancer Risk

FDA Approves Foundation Medicine CDx for Novartis Breast Cancer Drug Piqray

Illumina, ArcherDx Expand Partnership on NGS IVD Tests

Ambry Genetics, Caris Life Sciences Partner on Cancer Genetic Testing

Veracyte Exclusively Licenses NanoString Diagnostic Platform for Up to $60M

Sponsorships